ArticleGene therapy2019

Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.

Jarred M Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.